[PDF][PDF] Best Practices and Interventions for the Diagnosis and Treatment of Hepatitis C
A Part, B Part - Journal of Hepatology, 2009 - cagh-acsm.org
Background: Telaprevir is a hepatitis C NS3/4A protease inhibitor approved by the US Food
and Drug Administration as part of combination therapy for the management of chronic …
and Drug Administration as part of combination therapy for the management of chronic …